(Q45861413)

English

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gabriel N Hortobagyi

10

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

author name string

Massimo Cristofanilli

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Savitri Krishnamurthy

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Laura Guerra

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Kristine Broglio

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Banu Arun

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Daniel J Booser

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Kerstin Menander

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Jill Van Wart Hood

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Vicente Valero

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

107

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

935-944

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

21 January 2018

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive value of p53 and p21 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 expression as a prognostic marker in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Human gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Robust Locally Weighted Regression and Smoothing Scatterplots

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy -- promises, problems and prospects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of p53 in chemosensitivity and radiosensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoreticular infiltrates in invasive ductal breast cancer. A histological and immunohistological study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative/neoadjuvant medical therapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22080

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22080

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16874816

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45861413&oldid=2086786936"